IEQ Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
IEQ Capital's NEO Position: Q3 2026 in Review
IEQ Capital reduced its NeoGenomics (NEO) stake by 50% in Q3 2026, selling an estimated $870K and leaving 51,770 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.
IEQ Capital first reported a position in NEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.52M in Q2 2026. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- IEQ Capital held 51,770 shares of NeoGenomics worth $950K as of Q3 2026.
- IEQ Capital sold 52,706 NeoGenomics shares in Q3 2026, an estimated $870K.
- NeoGenomics made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1097 holding.
- IEQ Capital first reported a position in NeoGenomics in Q2 2025 and has held it in 5 quarters since.
- IEQ Capital's NeoGenomics position peaked at $1.52M in Q2 2026.
- 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.